Recent biomarkers advances, including detection of misfolded α-synuclein aggregates through seed amplification assay, led to proposal of two similar but conceptually different approaches to improve integration of biological information in the definition and classification of PD or neuronal α-synuclein diseases. This evidence concerns the gene SNCA and Parkinson disease.